Tennessee 2025-2026 Regular Session

Tennessee Senate Bill SB2349

Caption

AN ACT to amend Tennessee Code Annotated, Title 68, relative to Charcot-Marie-Tooth Disease.

Summary

SB2349 directs the Tennessee Department of Health to create and run an outreach campaign focused on Charcot-Marie-Tooth disease, a rare inherited neurological disorder. The campaign may use print, radio, social media, television public service announcements, advertisements, posters, and other materials to publicize ongoing research in Tennessee. The department must also establish and promote a toll-free phone line or web-based hotline where individuals can report a diagnosis of Charcot-Marie-Tooth disease or donate to research related to the disease. The bill also specifies broad program components for the outreach effort, including data portal development and security, community outreach and public service announcements, honoraria, strategy and travel, materials and toolkits, media, and program evaluation and contingency planning. The outreach campaign is set to end on July 1, 2027, and the act would take effect on July 1, 2026.

Impact

The bill would add a new public-health outreach and awareness program within Title 68 of the Tennessee Code, assigning the Department of Health responsibility for disease education, reporting, and research promotion related to Charcot-Marie-Tooth disease. It does not create a treatment mandate or insurance requirement, but it does require the state to build communication infrastructure, maintain a hotline or web portal, and support data collection and public engagement efforts for a defined period.

Sentiment

The available voting history suggests the bill was received favorably in committee, passing the Senate Health and Welfare Committee 9-0 and being recommended for passage. No committee transcript is available, but the unanimous vote indicates broad support and little visible opposition at that stage. The bill appears framed as a public-health and research-awareness measure rather than a controversial regulatory change.

Contention

There is little evidence of substantive contention in the available record. The main practical questions likely concern the cost and administration of the outreach campaign, including data portal security, staffing, travel, materials, and evaluation, which are explicitly listed in the bill. Any debate would likely center on whether state resources should be used for a disease-specific awareness campaign and hotline versus other public-health priorities, but no recorded objections are provided.

Companion Bills

TN HB2092

Crossfiled AN ACT to amend Tennessee Code Annotated, Title 68, relative to Charcot-Marie-Tooth Disease.

Previously Filed As

TN HB2092

AN ACT to amend Tennessee Code Annotated, Title 68, relative to Charcot-Marie-Tooth Disease.

TN HJR0120

A RESOLUTION relative to a voluntary reporting system for Charcot-Marie-Tooth Disease in Tennessee.

TN HR1079

Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

TN HB0383

AN ACT to amend Tennessee Code Annotated, Title 4; Title 63 and Title 68, relative to reportable diseases.

TN SB0744

AN ACT to amend Tennessee Code Annotated, Title 4; Title 63 and Title 68, relative to reportable diseases.

TN SB1031

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 68, relative to relative to drug labels.

TN HB1157

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 68, relative to relative to drug labels.

TN HB2075

AN ACT to amend Tennessee Code Annotated, Title 9; Title 33; Title 53; Title 63 and Title 68, relative to clinical trials.

TN HB1443

AN ACT to amend Tennessee Code Annotated, Title 9; Title 33; Title 52; Title 67 and Title 68, relative to relief for caregivers of individuals with Alzheimer's disease or related dementia.

TN SB1777

AN ACT to amend Tennessee Code Annotated, Title 9; Title 33; Title 52; Title 67 and Title 68, relative to relief for caregivers of individuals with Alzheimer's disease or related dementia.

Similar Bills

No similar bills found.